JAKARTA - PT Kimia Farma Tbk signed a memorandum of understanding (MoU) with the National Research and Innovation Agency (BRIN) which includes research, development, assessment and application as well as intervention and innovation in the health sector.
The signing was attended by the President Director of PT Kimia Farma Tbk, David Utama and his staff and the Acting Deputy for Research Utilization & Innovation of BRIN, Dr. R. Hendrian, M.Sc. along with the ranks.
Kimia Farma's Corporate Communication Manager Hilda Shinta explained that Kimia Farma and BRIN agreed to synergize in the use of facilities and infrastructure owned by each party.
"In addition, Kimia Farma and BRIN also agreed on an exchange of personnel and/or experts as well as the development of human resources," he said in a statement received by VOI, Wednesday, October 12.
In addition, there is also a commercialization and utilization of research and innovation results into scope in the signing of this MoU.
He added that the signing of this memorandum of understanding will create collaboration and optimization of every potential owned by both parties to produce and succeed in innovation and intervention.
"So, the more innovative products and services made by the nation's children can be mitigated and used to strengthen the nation's health," he concluded.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
Most Popular Tags
#Prabowo Subianto #New Year #pdip #Hasto Kristiyanto #nataru #NatalPopular
